CHANG NANCY T
Insider CIK 1135041 · WTI Director · GRTX Director, 10% owner · IMMX Director · SCLN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GRTX Galera Therapeutics, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-05 | 480 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 47,434 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer deriv | 2026-08-03 | 2026-08-05 | 480 | — | — | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | D To issuer | 2026-08-03 | 2026-08-05 | 47,434 | — | — | 0 | SEC↗ |
| WTI W&T OFFSHORE INC | S Sale | 2026-07-15 | 2026-07-16 | 60,000 | $3.31 | $198.6K | 156,100 | SEC↗ |
| WTI W&T OFFSHORE INC | M Exercise deriv | 2026-06-03 | 2026-06-05 | 103,448 | — | $0 | 0 | SEC↗ |
| WTI W&T OFFSHORE INC | A Award deriv | 2026-06-03 | 2026-06-05 | 35,972 | — | $0 | 35,972 | SEC↗ |
| WTI W&T OFFSHORE INC | M Exercise | 2026-06-03 | 2026-06-05 | 103,448 | — | $0 | 216,100 | SEC↗ |
| IMMX Immix Biopharma, Inc. | A Award deriv | 2026-05-22 | 2026-05-29 | 12,500 | — | $0 | 12,500 | SEC↗ |
| IMMX Immix Biopharma, Inc. | A Award | 2026-05-22 | 2026-05-29 | 6,250 | — | $0 | 428,190 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2026-05-15 | 2026-08-05 | 661 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2026-05-15 | 2026-08-05 | 661,309 | — | $0 | 9,486,852 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2026-05-15 | 2026-08-05 | 661 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2026-05-15 | 2026-08-05 | 661,309 | — | — | 9,486,852 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2026-04-07 | 2026-04-09 | 1,181 | — | $0 | 661 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2026-04-07 | 2026-04-09 | 1,180,611 | — | $0 | 8,825,543 | SEC↗ |
| IMMX Immix Biopharma, Inc. | A Award deriv | 2025-11-21 | 2025-12-11 | 39,643 | — | $0 | 39,643 | SEC↗ |
| WTI W&T OFFSHORE INC | A Award deriv | 2025-06-03 | 2025-06-05 | 103,448 | — | $0 | 103,448 | SEC↗ |
| WTI W&T OFFSHORE INC | M Exercise deriv | 2025-06-03 | 2025-06-05 | 73,892 | — | $0 | 0 | SEC↗ |
| WTI W&T OFFSHORE INC | M Exercise | 2025-06-03 | 2025-06-05 | 73,892 | — | $0 | 112,652 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 96,000 | — | $0 | 96,000 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | A Award deriv | 2024-12-30 | 2025-01-02 | 1,842 | — | $0 | 1,842 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2024-12-30 | 2025-01-02 | 7,644,932 | $0.07 | $535.1K | 7,644,932 | SEC↗ |
| WTI W&T OFFSHORE INC | M Exercise deriv | 2024-06-17 | 2024-06-18 | 38,760 | — | $0 | 0 | SEC↗ |
| WTI W&T OFFSHORE INC | M Exercise | 2024-06-17 | 2024-06-18 | 38,760 | — | $0 | 38,760 | SEC↗ |
| WTI W&T OFFSHORE INC | A Award deriv | 2024-06-14 | 2024-06-18 | 73,892 | — | $0 | 73,892 | SEC↗ |
| WTI W&T OFFSHORE INC | A Award deriv | 2023-07-03 | 2023-07-06 | 38,760 | — | $0 | 38,760 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $0.28 | $8.4K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer deriv | 2017-10-13 | 2017-10-16 | 30,000 | $2.03 | $60.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | D To issuer | 2017-10-13 | 2017-10-16 | 70,000 | $11.18 | $782.6K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2017-06-08 | 2017-06-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-09-29 | 2016-09-29 | 33,333 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2016-09-29 | 2016-09-29 | 7,648 | — | $0 | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-09-29 | 2016-09-29 | 7,648 | $5.10 | $39.0K | 36,667 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2016-09-29 | 2016-09-29 | 33,333 | $5.22 | $174.0K | 70,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-30 | 2016-08-30 | 7,540 | $10.33 | $77.9K | 0 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-29 | 2016-08-30 | 10,000 | $10.31 | $103.1K | 7,540 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | S Sale | 2016-08-26 | 2016-08-30 | 7,500 | $10.25 | $76.9K | 17,540 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2016-06-09 | 2016-06-13 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-06-11 | 2015-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2015-02-12 | 2015-02-13 | 16,667 | — | $0 | 33,333 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise deriv | 2015-02-12 | 2015-02-13 | 12,352 | — | $0 | 7,648 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2015-02-12 | 2015-02-13 | 16,667 | $5.22 | $87.0K | 54,059 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | M Exercise | 2015-02-12 | 2015-02-13 | 12,352 | $5.10 | $63.0K | 37,392 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | P Buy | 2014-08-15 | 2014-08-19 | 25,040 | $6.00 | $150.2K | 25,040 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2014-06-12 | 2014-06-16 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SCLN SCICLONE PHARMACEUTICALS I | A Award deriv | 2013-09-17 | 2013-09-19 | 50,000 | — | $0 | 50,000 | SEC↗ |